Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

According to an announcement by Pfizer Inc (PFE) on Wednesday, the company is to be split into three units – Innovative Medicines, Established Medicines and Consumer Healthcare. At present, Pfizer is organized in two units – Innovative Medicines, which also encompasses the companys consumer business, and Essential Health.

The reorganization is to come into effect at the beginning of fiscal 2019.

Pfizer shares closed lower for the first time in the past seven trading sessions in New York on Wednesday. The stock went down 0.59% ($0.22) to $37.21, after touching an intraday low at $37.16, or a price level not seen since July 9th ($37.01).

Shares of Pfizer Inc have risen 2.73% so far in 2018 compared with a 3.76% gain for the underlying index, S&P 500 (SPX).

In 2017, Pfizer Inc’s stock went up 11.51%, thus, it again underperformed the S&P 500, which registered a 19.42% return.

Once the changes take place, Pfizers Innovative Medicines business will also encompass biosimilars and a new hospital business unit. Innovative Medicines, together with Consumer Healthcare, is expected to generate about three-quarters of Pfizers annual revenue.

At the same time, the Established Medicines business is to encompass most of Pfizers off-patent brands. The latter include neurological disease treatment Lyrica, Viagra and several generic drugs.

Last October, Pfizer announced that it was exploring the spin-off or sale of its Consumer Healthcare unit, while in May this year it said that an acceptable offer had not yet been received. Pfizers Consumer Healthcare business is evaluated at approximately $15 billion.

According to CNN Money, the 21 analysts, offering 12-month forecasts regarding Pfizer Inc’s stock price, have a median target of $41.00, with a high estimate of $48.00 and a low estimate of $31.00. The median estimate represents a 10.19% upside compared to the closing price of $37.21 on July 11th.

The same media also reported that 9 out of 20 surveyed investment analysts had rated Pfizer Inc’s stock as “Buy”, while 8 – as “Hold”. On the other hand, 1 analyst had recommended selling the stock.

Daily and Weekly Pivot Levels

With the help of the Camarilla calculation method, todays levels of importance for the Pfizer stock are presented as follows:

R1 – $37.23
R2 – $37.26
R3 (Range Resistance – Sell) – $37.28
R4 (Long Breakout) – $37.35
R5 (Breakout Target 1) – $37.43
R6 (Breakout Target 2) – $37.46

S1 – $37.19
S2 – $37.16
S3 (Range Support – Buy) – $37.14
S4 (Short Breakout) – $37.07
S5 (Breakout Target 1) – $36.99
S6 (Breakout Target 2) – $36.96

By using the traditional method of calculation, the weekly levels of importance for Pfizer Inc (PFE) are presented as follows:

Central Pivot Point – $36.78
R1 – $37.57
R2 – $38.02
R3 – $38.81
R4 – $39.59

S1 – $36.33
S2 – $35.54
S3 – $35.09
S4 – $34.63

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Merck increases quarterly dividend to $0.81Merck increases quarterly dividend to $0.81 Merck & Company Inc (NYSE: MRK) said on Tuesday that its Board of Directors had authorized a regular quarterly cash dividend of $0.81 per share of common stock.The latter represents an increase of 5.19% compared to the previous quarterly […]
  • British pound, on its part, also moved up against US dollarBritish pound, on its part, also moved up against US dollar During Thursday trade session British pound recorded upward movement versus US dollar, as an effect of greenbacks continuing weakness versus Japanese yen and other major peers.GBP/USD reached 1.5187 during early European session, currently […]
  • Forex Market: GBP/USD daily trading outlookForex Market: GBP/USD daily trading outlook Yesterday’s trade saw GBP/USD within the range of 1.4188-1.4280. The pair closed at 1.4189, shedding 0.50% on a daily basis. It has been the 40th drop in the past 73 trading days and also the sharpest one since April 5th, when the pair went […]
  • Switzerland’s retail sales rise below forecast in MaySwitzerland’s retail sales rise below forecast in May Retail sales in Switzerland were reported to have risen 0.4% year-on-year in May. That followed a revised down 2.2% surge in April, data by the Swiss Federal Statistical Office showed.The latest figure came in well below market […]
  • Forex Market: USD/JPY daily trading forecastForex Market: USD/JPY daily trading forecast Friday’s trade saw USD/JPY within the range of 124.08-125.08. The pair closed at 124.22, down 0.42% on a daily basis, or the most considerable daily loss since July 27th, when it depreciated 0.42%. The daily high has also been the highest […]
  • US dollar continued its advance against the Swiss franc, US employment report eyedUS dollar continued its advance against the Swiss franc, US employment report eyed US dollar managed to extend its advance against the Swiss franc on Friday, as market sentiment was dominated by expectations of a positively-toned report, regarding US employment in June.USD/CHF jumped to a session high at 0.9595 at 7:18 […]